Related Experiment Video
Updated: Aug 17, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
PKB mediates c-erbB2-induced epithelial beta1 integrin conformational inactivation through Rho-independent F-actin
Shahram Hedjazifar1, Lachmi E Jenndahl, Hiroaki Shimokawa
1Department of Medical Biochemistry, University of Göteborg, Box 440, SE-405 30 Göteborg, Sweden.
Abstract:
Signalling from the growth factor receptor subunit and proto-oncogene c-erbB2 has been shown to inhibit the adhesive function of the collagen receptor integrin alpha(2)beta(1) in human mammary epithelial cells. This anti-adhesive effect is mediated by the MAP ERK kinase 1/2 (MEK1/2) and protein kinase B (PKB) pathways. Here, we show that both pathways mediate suppression of matrix adhesion by causing the extracellular domain of the beta(1) integrin subunit to adopt an inactive conformation. The conformational switch was also dependent on rapid and extensive actin depolymerisation. While neither activation nor inhibition of the Rho GTPase affected this rearrangement, Rho was found to be activated by c-erbB2 and to be necessary for conformation-dependent integrin inactivation and, apparently by a different mechanism, a delayed re-formation of stress fibers which did not restore integrin function. Interestingly, the initial actin depolymerisation as well as its effects on integrin function was shown to be mediated by PKB. These results demonstrate how oncogenic growth factor signalling inhibits matrix adhesion by multiple pathways converging on integrin conformation and how Rho signalling can profoundly influence integrin activation in a cytoskeleton-independent manner.
Insights
Proto-oncogene c-erbB2 signaling inhibits cell adhesion by altering integrin conformation via MEK1/2 and PKB pathways. This involves actin depolymerization and Rho GTPase activation, impacting cell matrix interactions.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Proto-oncogene c-erbB2 signaling inhibits integrin alpha(2)beta(1) adhesive function in mammary epithelial cells.
- This inhibition is mediated by MAP ERK kinase 1/2 (MEK1/2) and protein kinase B (PKB) pathways.
Purpose of the Study:
- To elucidate the mechanisms by which c-erbB2 signaling suppresses matrix adhesion.
- To investigate the role of integrin conformation, actin cytoskeleton, and Rho GTPase in this process.
Main Methods:
- Analysis of integrin alpha(2)beta(1) conformation and function in human mammary epithelial cells.
- Investigation of the involvement of MEK1/2, PKB, and Rho GTPase signaling pathways.
- Assessment of actin depolymerization and stress fiber formation.
Main Results:
- c-erbB2 signaling induces an inactive conformation of the beta(1) integrin subunit via MEK1/2 and PKB.
- Actin depolymerization is essential for this conformational switch.
- Rho GTPase is activated by c-erbB2 and is necessary for integrin inactivation and delayed stress fiber reformation.
Conclusions:
- Oncogenic growth factor signaling inhibits matrix adhesion through multiple pathways converging on integrin conformation.
- PKB mediates initial actin depolymerization and its effects on integrin function.
- Rho signaling influences integrin activation independently of the cytoskeleton.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

